Evidence map›Paper›PMID 41670729›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2026

Bystander effects in photodynamic therapy-treated tumors involve spatiotemporally extended ferroptosis.

Mladen Korbelik, Albert W Girotti, David Kessel

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mladen KorbelikDepartment of Integrative Oncology, BC Cancer, Vancouver, BC, V5Z 1L3, Canada. mkorbelik@bccrc.ca.ORCID http://orcid.org/0000-0002-6162-2319
Albert W GirottiDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.ORCID http://orcid.org/0000-0002-8881-5102
David KesselDepartment of Pharmacology, Wayne State University School of Medicine, Detroit, MI, 48201, USA.ORCID http://orcid.org/0000-0002-3221-9299

Funding

Advancing a Healthier Wisconsin Research and Education Foundation 5520347NCI NIH HHS CA70823
6 · The paper itself

Abstract

The tumor bystander effect describes the ability of cells sustaining therapeutic treatment damage to transmit distress signals to neighboring unharmed cells and change their behavior. Photodynamic therapy (PDT), which uses light for activation of photosensitizing drugs in targeted lesions to produce cytotoxic damage, is one of the cancer treatment modalities inducing highly robust bystander effects. This is caused to a large extent by the propensity of PDT for creating extensive lipid peroxidation damage and related instigation of ferroptotic cell death. Lipid peroxides appear to be major participants in intercellular signaling generating the bystander effect and orchestrating ferroptosis that appears to have a pivotal role in propagating the lethal (therapeutically beneficial) form of bystander response. In contrast, nitric oxide (NO) released from PDT-treated cancer cells has emerged as a major signal for therapeutically detrimental bystander effects due to promoting tumor growth and metastasis. It is becoming increasingly evident that exploiting the bystander response can be an attractive strategy for improving tumoricidal depth with consequently elevated tumor cure rates following PDT treatment. A two-pronged approach is proposed for achieving this goal: (i) inactivating iNOS enzyme with a specific pharmacologic inhibitor, and (ii) amplifying the induction of cytotoxic ferroptosis in nearby cells initially unaffected by photodamage, thereby limiting their ability to promote tumor expansion.

Indexed as

Bystander EffectFerroptosisNeoplasmsPhotochemotherapyAnimalsHumansLipid PeroxidationNitric OxidePhotosensitizing AgentsNitric OxidePhotosensitizing AgentsBystander effectFerroptosisLipid peroxidationNitric oxidePhotodynamic therapy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.